Improved in vivo targeting of BCL-2 phenotypic conversion through hollow gold nanoshell delivery. Read more about Improved in vivo targeting of BCL-2 phenotypic conversion through hollow gold nanoshell delivery.
Cancer therapeutics based on BCL-2 functional conversion. Read more about Cancer therapeutics based on BCL-2 functional conversion.
The aryl hydrocarbon receptor is required for induction of p21cip1/waf1 expression and growth inhibition by SU5416 in hepatoma cells. Read more about The aryl hydrocarbon receptor is required for induction of p21cip1/waf1 expression and growth inhibition by SU5416 in hepatoma cells.
Identification of a Raloxifene Analog That Promotes AhR-Mediated Apoptosis in Cancer Cells. Read more about Identification of a Raloxifene Analog That Promotes AhR-Mediated Apoptosis in Cancer Cells.
Induction of apoptosis and suppression of tumor growth by Nur77-derived Bcl-2 converting peptide in chemoresistant lung cancer cells. Read more about Induction of apoptosis and suppression of tumor growth by Nur77-derived Bcl-2 converting peptide in chemoresistant lung cancer cells.
Identification of a Raloxifene Analog That Promotes AhR-Mediated Apoptosis in Cancer Cells Read more about Identification of a Raloxifene Analog That Promotes AhR-Mediated Apoptosis in Cancer Cells
